1. Home
  2. JAZZ vs CX Comparison

JAZZ vs CX Comparison

Compare JAZZ & CX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Jazz Pharmaceuticals plc (Ireland)

JAZZ

Jazz Pharmaceuticals plc (Ireland)

HOLD

Current Price

$223.73

Market Cap

15.0B

Sector

Health Care

ML Signal

HOLD

Logo Cemex S.A.B. de C.V. Sponsored ADR

CX

Cemex S.A.B. de C.V. Sponsored ADR

HOLD

Current Price

$12.84

Market Cap

17.0B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
JAZZ
CX
Founded
2003
1906
Country
Ireland
Mexico
Employees
N/A
39462
Industry
Biotechnology: Pharmaceutical Preparations
Building Materials
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
15.0B
17.0B
IPO Year
2007
N/A

Fundamental Metrics

Financial Performance
Metric
JAZZ
CX
Price
$223.73
$12.84
Analyst Decision
Strong Buy
Buy
Analyst Count
14
8
Target Price
$217.57
$12.21
AVG Volume (30 Days)
765.4K
3.7M
Earning Date
05-05-2026
04-23-2026
Dividend Yield
N/A
0.74%
EPS Growth
N/A
N/A
EPS
4.43
N/A
Revenue
$1,618,693,000.00
N/A
Revenue This Year
$6.22
$8.28
Revenue Next Year
$7.68
$4.34
P/E Ratio
$50.77
$19.03
Revenue Growth
N/A
N/A
52 Week Low
$105.00
$6.67
52 Week High
$243.32
$13.67

Technical Indicators

Market Signals
Indicator
JAZZ
CX
Relative Strength Index (RSI) 45.70 51.16
Support Level $224.23 $11.61
Resistance Level $242.66 $13.15
Average True Range (ATR) 6.87 0.44
MACD -2.13 -0.01
Stochastic Oscillator 18.45 61.71

Price Performance

Historical Comparison
JAZZ
CX

About JAZZ Jazz Pharmaceuticals plc (Ireland)

Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.

About CX Cemex S.A.B. de C.V. Sponsored ADR

Cemex SAB de CV is a ready-mix concrete company that mainly engaged in activities that are oriented to the construction industry, mainly through the production, marketing, sale, and distribution of cement, ready-mix concrete, aggregates, urbanization solutions, and other construction materials and also provide related services and reliable construction-related services to customers and communities and maintain business relationships in more than 60 countries throughout the world. The company operates in different parts of the world, with operations in Mexico, the United States, the EMEA region and the SCA&C region.

Share on Social Networks: